Research
-
Active
March 2024 - January 2024
Can nicotinamide protect and restore retinal ganglion cells in a model of autosomal dominant optic neuropathy?
2024 - RESSGA2312 - Cimaglia -
Active
February 2024 - January 2025
Developing a model to study uveitis
2024 - RESSGA2311 - Wickramasinghe -
Completed
January 2024 - July 2024
Identifying potential targets for the monitoring and treatment of thyroid eye disease (TED)
2024 - RESSGA2310 - Hanna -
Starting soon
November 2024 - May 2027
Analysis of Electroretinography using Artificial Intelligence with embedded safety features.
2024 - RESPRJ2304 - Robson -
Active
October 2024 - October 2027
Galectin-3 as a determinant of T cell-driven pathology: targeting galectin-3 to restore tissue integrity in uveitis and arthritis-associated uveitis.
2024 - RESPRJ2301 - Jones -
Active
September 2024 - September 2027
Developing mitochondrial-targeted therapies for the multisystem management of diabetic eye disease
2024 - RESPRJ2303 - Hombrebueno -
Active
September 2024 - August 2027
Tear proteomics and electrophysiology in infants at risk of retinopathy of prematurity
2024 - RESPRJ2306 - Houtman -
Active
June 2024 - November 2024
Corneal Nanoinjection: a nanoneedle platform for gene editing in inherited corneal endothelial disorders
2024 - RESPRJ2302 - Chiappini -
Active
June 2024 - May 2027
Characterisation of the smooth zone of retinal autofluorescence in the macula of choroideremia patients as a biomarker for use as an approvable endpoint in a pivotal gene therapy trial
2024 - RESPRJ2305 - MacLaren